These activated dendritic cells are then able to stimulate both CD8 T cells [61], in addition to helper CD4 T cells [62] and/or natural killer cells, as the tumor protection resulting from ILV/mIL12 administration was lost when these populations were depleted. The gene discussed is CD4; the disease is neoplasm.